| Annual Financials | 2024 | 2025 | 2026 | TTM |
Revenue  | 32 | 50 | 71 | 21 |
| Expenses | 28 | 44 | 63 | 19 |
| EBITDA | 4 | 6 | 8 | 2 |
| Operating Profit % | 13 % | 11 % | 12 % | 5 % |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 6 | 8 | 2 |
| Tax | 1 | 1 | 2 | 1 |
| Net Profit | 3 | 4 | 6 | 2 |
| EPS in ₹ | 19.96 | 4.01 | 4.68 | 1.60 |
Medistep Healthcare
Medistep Healthcare
19.55
0.00
(0.00%)
Market Cap
27.78 Cr
PE Ratio
4.64
Volume
0.00
Day High - Low
- - -
52W High-Low
53.00 - 16.50
Key Fundamentals
Market Cap
27.78 Cr
EPS
4.68
PE Ratio
4.64
PB Ratio
0.73
Book Value
26.62
EBITDA
8.25
Dividend Yield
0.00 %
Industry
Consumer Goods Sector
Personal Care Return on Equity
24.62
Debt to Equity
0.03
Actual
Company News
View All News
Medistep Healthcare reported a 44.4% rise in net profit to ₹598.30 lakh for FY26. Revenue from operations increased 42.6% to ₹7,083.10 lakh.
Medistep Promoters Confirm No Encumbrance
May 21, 2026
May 21, 2026Medistep Healthcare promoters confirm no encumbrance on shares for FY26. Declaration submitted to NSE on April 2, 2026.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,013.20 | #1 1,03,675.14 | 54.75 | #1 15,100.10 | 2.86 | #1 1,985 | 9.69 | 45.40 | |
426.15 | 75,585.81 | 39.85 | 13,192.60 | 0.61 | 1,883 | 15.77 | 39.74 | |
2,023.40 | 55,033.57 | 41.20 | 5,983.57 | -3.16 | 1,316 | -0.48 | 41.96 | |
9,032.50 | 29,320.16 | 34.65 | 4,281.59 | 25.49 | 863 | -1.92 | 32.44 | |
7,657.50 | 24,952.13 | 37.97 | 3,099.53 | 36.98 | 648 | 21.30 | 43.25 | |
145.86 | 19,613.22 | 175.50 | 357.71 | 76.04 | 110 | #1 215.65 | 77.97 | |
390.90 | 17,062.79 | #1 21.68 | 3,779.51 | -2.52 | 757 | -11.71 | 33.50 | |
407.95 | 13,273.46 | 67.53 | 2,391.94 | 11.48 | 197 | 177.60 | 65.87 | |
582.20 | 7,604.60 | 39.48 | 1,153.43 | 15.30 | 190 | 105.16 | 65.72 | |
1,183.45 | 2,140.46 | 63.06 | 137.42 | #1 78.24 | 36 | - | 66.22 |
Growth Rate
Revenue Growth
42.52 %
Net Income Growth
46.10 %
Cash Flow Change
100.28 %
ROE
-1.20 %
ROCE
-1.46 %
EBITDA Margin (Avg.)
3.19 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 15 | 23 | 50 |
| Fixed Assets | 0 | 0 | 0 |
| Current Assets | 15 | 23 | 50 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 6 |
| Other Assets | 15 | 23 | 0 |
| Total Equity & Liabilities | 15 | 23 | 50 |
| Current Liabilities | 3 | 6 | 12 |
| Non Current Liabilities | 0 | 0 | 0 |
| Total Equity | 12 | 17 | 38 |
| Reserve & Surplus | 7 | 6 | 24 |
| Share Capital | 5 | 11 | 14 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | 0 | 1 |
| Investing Activities | -0 | 0 |
| Operating Activities | -7 | 0 |
| Financing Activities | 7 | 1 |
Share Holding
| % Holding | Dec 2024 | Aug 2025 | Sept 2025 | Mar 2026 |
| Promoter | 93.62 % | 68.96 % | 68.96 % | 68.96 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 27.29 % | 26.61 % | 27.54 % |
| Others | 6.38 % | 3.76 % | 4.43 % | 3.50 % |
| No of Share Holders | 8 | 8 | 578 | 514 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Nov 2025 |  Quarterly Result Announcement | NA | 11 Nov 2025 | 26.00 | 24.15 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 18.20 | 18.00 |
Technical Indicators
RSI(14)
Neutral 49.11
ATR(14)
Volatile 1.62
STOCH(9,6)
Neutral 47.76
STOCH RSI(14)
Neutral 42.35
MACD(12,26)
Bearish -0.11
ADX(14)
Weak Trend 14.74
UO(9)
Bearish 47.54
ROC(12)
Downtrend And Accelerating -5.78
WillR(14)
Neutral -42.86
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
